730 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by GAMMA Investing LLC

GAMMA Investing LLC bought a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 730 shares of the biopharmaceutical company’s stock, valued at approximately $688,000. A number of other institutional investors have also made changes to their positions in REGN. Meyer Handelman […]

Related Keywords

Andrewj Murphy ,Sanfordc Bernstein ,Arthurf Ryan , ,Regeneron Pharmaceuticals ,Morgan Stanley ,News Ratings For Regeneron Pharmaceuticals Daily ,Regeneron Pharmaceuticals Inc ,Stifel Financial Corp ,Cavalier Investments ,Meyer Handelman Co ,Quarter For Regeneron Pharmaceuticals ,Exchange Traded Concepts ,Barclays ,Nasdaq ,Regeneron Pharmaceuticals Company Profile ,Regeneron Pharmaceuticals Price Performance ,Holdings Channel ,Gamma Investing ,Free Report ,Financial Corp ,Traded Concepts ,Get Free Report ,Director Arthur ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,